XML 49 R36.htm IDEA: XBRL DOCUMENT v3.25.3
EQUITY (Tables)
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Warrants Outstanding and Exercisable The following table summarizes the status of warrants and related transactions:
Non-Derivative (Equity) Warrants
Derivative Liabilities Warrants
Total Number of WarrantsWeighted - Average Exercise Price
Balance as of January 1, 2025
50,518,53621,400,00071,918,536$1.03 
Granted (1)
8,210,626 — 8,210,626 $0.48 
Balance as of September 30, 2025
58,729,16221,400,00080,129,162$0.98 
Exercisable as of September 30, 2025
57,509,16221,400,00078,909,162$0.98 
(1)In February 2025, the Company issued 8,010,626 warrants in connection with Second Lien Notes issuances. Refer to Note 8 - Debt for more information.
Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions The following assumptions were used for the calculation at date of issuance:
Weighted average stock price$0.33
Weighted average expected stock price volatility91.8%
Expected annual dividend yield0%
Weighted average expected life of warrants
5.0 years
Weighted average risk-free annual interest rate4.1%
Weighted average grant date fair value$0.22
Schedule of Stock Options Outstanding
The following table summarizes the status of stock options and related transactions:
Number of Stock OptionsWeighted-Average Per Share Exercise Price
Issued and Outstanding as of January 1, 202526,769,419 $0.79 
Granted1,120,000 $0.42 
Cancelled/forfeited/expired(3,444,834)$0.82 
Issued and Outstanding as of September 30, 202524,444,585 $0.77 
Exercisable as of September 30, 202518,507,055 $0.85 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following assumptions were used for the calculation at date of grant:
Nine Months Ended September 30,
20252024
Weighted average stock price$0.41$0.56
Weighted average expected stock price volatility92.8%86.9%
Expected annual dividend yield0%0%
Weighted average expected life5.1 years5.0 years
Weighted average risk-free annual interest rate3.9%3.6%
Weighted average grant date fair value$0.30$0.21
Schedule of Components of Share-based Compensation Expense
The components of share-based compensation expense, net, are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Stock options
$261 $982 $187 $2,931 
Restricted stock— — — 2 
Warrants96 100 237 20 
Total share-based compensation expense, net
$357 $1,082 $424 $2,953